Physician profile
Jack Tsao
NPI 1437135084
$15,862.80
in general payments reported to CMS, 2019-2025
10 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $594 · 2020: $22.00 · 2021: $8,097 · 2022: $4,052 · 2024: $2,989 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,700 · Food and Beverage: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,700.00 |
| Food and Beverage | $398.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $12,167.94 | 2019-2022 | |
| Abbvie INC. | $2,803.39 | 2024-2025 | |
| Merz North America, INC. | $217.27 | 2019 | |
| Genentech USA, INC. | $135.37 | 2019 | |
| Lilly USA, LLC | $125.00 | 2024 | Kisunla |
| Greenwich Biosciences, INC. | $120.17 | 2019 | |
| Alexion Pharmaceuticals, INC. | $101.70 | 2019 | |
| Pfizer INC. | $90.42 | 2024 | |
| Life Molecular Imaging LTD | $79.54 | 2025 | Neuraceq |
| Teva Pharmaceuticals USA, INC. | $22.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Tsao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.